Since the SEC probe was disclosed last week

Quote

Anonymous

Guest
in the 10-q, the new new management team can now focus of turning the company into a successful business. Remember when Sam Waksal went to jail for insider trading of Imclone stock with knowledge of the FDA's RTF. Who took Imclone from chaos to successful launch of Erbitux and on to eventual sale of the company to Lilly other than our current CEO John Johnson. I think he will repeat that same success with Dendreon.
 






Johnson was on the board of directors when all this illicit activity was going on at Dendreon. If he was on the board at Imclone at the time maybe your point could be well taken (don't know if he was or wasn't). A board's job is oversight and it seems apparent that this board let Gold do whatever he wanted and hire whoever he wanted. Board's are culpable when the people they are responsible to have oversight of break federal securities laws. The class action suits have even dicusssed the board's culpability.
 






You are completely wrong on both counts:

- Johnson joined Dendreon's board on August 18, 2012, well after Gold's mess was outed and 3 weeks after the infamous conference call.
- Johnson took over as CEO of Imclone after Sam Waksal nearly destroyed the company and completely turned Imclone around.
- Let's hope Johnson can do the same thing for Dendreon and turn it into a highly successful company.

http://investor.dendreon.com/releasedetail.cfm?ReleaseID=600345


August 22, 2011
Dendreon Announces Election of John H. Johnson to Board of Directors


SEATTLE--(BUSINESS WIRE)-- Dendreon Corporation (Nasdaq: DNDN) today announced that John H. Johnson has been elected to the Company's Board of Directors, effective August 18, 2011. Mr. Johnson is currently the chief executive officer of Savient Pharmaceuticals, Inc. (Nasdaq: SVNT), where he has also served as a member of its Board of Directors since January 2011.

"John has broad commercial experience in numerous therapeutic categories, and we welcome him and his recent and highly relevant oncology expertise to Dendreon's Board of Directors," said Richard. B. Brewer, chairman of the Dendreon Board of Directors.

Prior to joining Savient Pharmaceuticals, Inc., Mr. Johnson served as president of Eli Lilly & Company's Oncology Business Unit, where he was responsible for multi-billion dollar franchise including a development portfolio of over 30 oncology products following the company's 2008 acquisition of Imclone Systems, Inc., where he served as chief executive officer. While at Imclone, Mr. Johnson managed the market expansion of colorectal cancer treatment Erbitux, overseeing the global growth of the billion dollar brand and eventual sale of the company to Eli Lilly for $6.5 billion.
 






Big difference between Erbitux and Provenge. Provenge is viewed more like a commodity rather than a necessity. Science behind the former was stronger than science of the latter. Emerging therapies in prostate cancer will make Provenge practically irrelevant in large scheme. JJ can't fix market sentiment.
 






Stick a fork in Dendreon. It is done.

As for MG, at some point we all have to meet our maker. He will not be judged kindly IMO. In the meantime, his life going forward should be a living hell. Hopefully he loses everything he stole from good honest hard working people which is just about everything he has.

He is very much in Joseph Nacchios league. Nacchio is in prison. If this guy doesnt go to prison then it would be unfair to Nacchio that he is in prison.
 






Actually, Provenge's survival benefit is far better than Erbitux. Please see Erbitux's label:

http://packageinserts.bms.com/pi/pi_erbitux.pdf

How could you think that Provenge would become irrelevant compared ton other late stage prostate cancer treatments? Provenge has a better survival benefit of 7.1 months when you account for placebo crossovers, provenge has very mild side effects, and provenge has a unique method of action, so it will be used in sequence with other therapies. Patients need to take steriods with Zytiga for heaven's sake. MDs get nearly $6,000 for administering provenge as opposed to $0 for writing a prescription of the competing drugs.

It is up to us as sales reps to improve market sentiment through excellent service and continued MD education. I see it improving from day to day.
 






This thread isn't about Provenge you dummy. It is a thread about the company that sells Provenge breaking federal laws and stealing money from hard working Americans. Now run along you "Care to Make (Lose) Money" propagandist.
 






Your the dummy. A "Company" can not break securities laws, only people can. The people that broke the law have for the most part already left the company, ie, Brewer, Bishop, Hamm, etc. The only person still at the Co. is Gold and his temporary term as Chairman ends on June 30th. Hopefully he will be moving to a jail cell soon.

The SEC probe has absolutely nothing to do with the reported financial results of the Company. It will have no effect on the company going forward. The SEC is looking at executives of the company who violated insider trading laws. The SEC is not looking to punish the employees of the company or shareholders of the company. The employees and the shareholders broke no laws.

Same thing with Imclone, CEO and Martha Stewart went to jail, followed by Johnson turning Imclone into a very successful company. Same thing will happen hear.

Provenge net sales are growing nicely from $49 million in Q2 of last year to $82 million in Q1 of this year. Many of the MDs I talk with like the product, like the $6,000 fee they earn, and will use provenge more in the future. Things should steadily improve with time. It takes years to build a successful commercial enterprise from scratch.
 






A company can be sued by investors and/or the government when their executives break federal securities. When it is the CEO and upper level executives it is appropriate to say the company.

Here is what the 10Q filing said:

"The Company has also become aware that the Securities and Exchange Commission (“SEC”) has commenced a formal investigation, which the Company believes may relate to some of the same issues raised in the securities and derivative actions."

Can a company become aware or do people become aware? Dendreon's lawyers wrote that the "company" became aware. Is that incorrect in your mind?

I agree with you that hopefully Gold will be moving to a jail cell soon, but you are incorrect that a company can not be sued for past crimes committed by people they fired just because those people were caught.

If the company intended to fire Gold, they would have done it not long after the August debacle. Gold was interviewed on CNBC in January and if you watch the interview, he did not seem like a man who knew he would be ousted by the end of the month. The FBI was investigating crimes well before January and IMO the company determined that Gold would probably be implicated in crimes and they ousted him. Same with Rob Rosen. These people were let go becasue they were caught. The company and individual defendants are being sued.

I wish every success for Provenge, but that success wont be achieved while Dendreon is the company that distributes it. You will see.

Only problem I have with your posts is that you are posting about Provenge in legal threads. Why not start a Provenge thread? Obviously you can do what you want but you are posting in inappropriate threads IMO.
 






Well obviously you do not work at Dendreon or even know what Provenge is. Provenge is not a product that is "distributed". Provenge is a treatment service that is provided.

Since you do not even understand the basics of what the product is, how can you have any clue about the future prospects of the company.

You wrote: "Gold was interviewed on CNBC in January and if you watch the interview, he did not seem like a man who knew he would be ousted by the end of the month." --- Obviously your crystal ball is wrong there as well since Gold was granted 460,000 shares at $0 basis just prior to that CNBC interview as a severance package of sorts. He was never awarded anything close to that amount for any prior period he was with the company. He did not receive those shares for his 2011 performance, it was a goodbye package.

The Company carries insurance to protect it from such director targeted lawsuits.

Provenge sales are improving and the company will do well in time.

The prior management which broke the rules are gone and are not running the company anymore.

New and well experienced management has taken over and is cleaning up the mess of prior management. So far they have done a good job.

You are obviously here to spread untrue negative rumors about the company for your own personal financial benefit.

The company is providing a valuable life extending service to cancer patients, please do not interfere with that.
 






Anonymous said:
Well obviously you do not work at Dendreon or even know what Provenge is. Provenge is not a product that is "distributed". Provenge is a treatment service that is provided.

Since you do not even understand the basics of what the product is, how can you have any clue about the future prospects of the company.

You wrote: "Gold was interviewed on CNBC in January and if you watch the interview, he did not seem like a man who knew he would be ousted by the end of the month." --- Obviously your crystal ball is wrong there as well since Gold was granted 460,000 shares at $0 basis just prior to that CNBC interview as a severance package of sorts. He was never awarded anything close to that amount for any prior period he was with the company. He did not receive those shares for his 2011 performance, it was a goodbye package.

The Company carries insurance to protect it from such director targeted lawsuits.

Provenge sales are improving and the company will do well in time.

The prior management which broke the rules are gone and are not running the company anymore.

New and well experienced management has taken over and is cleaning up the mess of prior management. So far they have done a good job.

You are obviously here to spread untrue negative rumors about the company for your own personal financial benefit.

The company is providing a valuable life extending service to cancer patients, please do not interfere with that.
Click to expand...

Sir if that was a "goodbye package" as you say then Dendreon omitted that in it's SEC filings. If you work for Dendreon, are you willing to go on record saying this was a severance package? Will you tell law enforcement this was a severance package? Will you explain to law enforcement why the whole board also got this "goodbye package"?

Here is what Dendreon said in the SEC filing:

Explanation of Responses:
( 1) 2011 Fin Perf RSA The award will vest ratably over 3 years based upon the achievement of Company performance goals

Is that a lie, sir? Was Dendreon omitting that this was a "goodbye package"?

Is this the interview of a man on January 10 2012 who knew he was "lame duck'?

http://video.cnbc.com/gallery/?video=3000066264

If you are a PR person working for Dendreon trying to "explain" to the public that Dendreon is removed from the atrocities of some former high level employees who were fired and/or continue to sit on the board of directors, then you dont understand the law and could get in to hot water due to your lack of understanding of the law.

As for Provenge, like I said before, I hope for the best for Provenge and all who are afflicted with the insidious disease cancer, however all companies must follow the law. All companies must treat employees with respect and truthfulness. All companies can not hire people under the false pretense of a falsely inflated stock price. All companies should not go without a chief compliance officer for 4 months while mass layoffs are going on and while its current CEO was on the board of directors. All companies can not break federal securities laws. Dendreon was the employer and in sorting this whole mess out Dendreon will be held to the same standard that other companies have been held to.

If Provenge is a great treatment it will thrive when it is free and clear of all the hurdles that Dendreon inflicted on it. We all have good intent and all want what is best for cancer patients. We are on the same page about many things. With that, I will end this conversation because I will not continue to respond to inaccuracies and someone who does not understand the law.
 






Hi Met-387 from the Yahoo finance board. You completely give yourself away with your use of the word "atrocities" in your mentally ill rants over and over and over again on cafepharma and yahoo finance. You do not work for Dendreon. You are a fraud.

You really are dense. Why was Gold awarded 460,000? As a reward for Dendreon's performance. He was pushed out for trading on insider information and completely mismanaging. I hope he winds up in jail.

Gold is no longer CEO. Gold has been completely sidelined. A new management team is in place. Provenge sales are increasing steadily quarter over quarter. Dendreon will do well despite your attempts to over run this board with your mentally ill rants.
 






I have no idea who that person is. I have never posted on yahoo finance or investors village. Yahoo finance posters are the lowest form of life. I look at those posts on occasion when I need a confidence boost about my own life. I am not an investor in Dendreon. I am an advocate for those who are victims of high level employees, board members and ex employees of Dendreon. I am not ranting. I am making legal arguments to someone who does not understand the law. I have seen multiple posters use the word "atrocities" on this board besides me. I definitely wasn't the first and won't be the last. Atrocities happened at Dendreon. Everyone knows that. You are a paranoid schiztophrenic to think you can identify posters on an anonymous buletin board. I bet you think 9/11 was in anside job too. Get lost with your schitzophrenic rants.
 






Sir, you said it was a severance package. If you work for Dendreon, then Dendreon should know that you are stating that it was a severance package to Gold. I told you that it was a "performance" bonus for 2011. That was the year Dendreon went from 35 to 7.

You are a paranoid wack job. Get help. If provenge is what you think it is then you will do great with your investment or your job with Dendreon. Why would you be involved with paranoia, name calling and lies unless you really don't have confidence that the product will be a money maker.
 






Gold still holds a very prestigious position with Dendreon as Chairman of the Board of Directors. His job is oversight of the CEO and company executives. Is this the person that should be policing the CEO and executives? This even makes less sense than if he remained CEO. How can someone like Gold be in a position to police the CEO and company executives? There is nothing this company does that makes any sense. Isn't Gold supposed to be leaving? If so, when?
 






Gold gives up the Chairman job on June 30, 2012:

SEATTLE--(BUSINESS WIRE)-- February 1, 2012 — Dendreon Corporation (Nasdaq: DNDN) today announced that its Board of Directors has elected John H. Johnson to the position of president and chief executive officer (CEO), to succeed Mitchell H. Gold, MD, who has served as president and CEO for nearly a decade. Dr. Gold has been elected executive chairman and will serve in that role until June 30, 2012, at which point he will continue to serve as a director and Mr. Johnson will become chairman.

http://investor.dendreon.com/releasedetail.cfm?ReleaseID=644470

Nice try though.
 












Top Bottom
Back
Quote